Medicine

U.S. approves Novartis drug Ilaris to treat childhood arthritis

• Bookmarks: 3


ZURICH (Reuters) – Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis.

Ilaris inhibits interleukin-1 beta, excessive production of which plays a prominent role in certain inflammatory diseases, the company said.

The drug is the only approved treatment specifically for the condition that can be given as a monthly subcutaneous injection, Novartis said.

Ilaris is also approved in the European Union for the treatment of refractory gouty arthritis, Novartis said.

(Reporting by Zurich Newsroom)

3 recommended
comments icon0 comments
0 notes
36 views
bookmark icon

Write a comment...

Your email address will not be published. Required fields are marked *